Johnson & Johnson (
) will begin trading ex-dividend on November 22, 2013. A cash
dividend payment of $0.66 per share is scheduled to be paid on
December 10, 2013. Shareholders who purchased JNJ stock prior to
the ex-dividend date are eligible for the cash dividend payment.
This marks the 3rd quarter that JNJ has paid the same dividend. At
the current stock price of $95.15, the dividend yield is 2.77%.
The previous trading day's last sale of JNJ was $95.15,
representing a -0.34% decrease from the 52 week high of $95.47 and
a 38.7% increase over the 52 week low of $68.60.
JNJ is a part of the Health Care sector, which includes
companies such as Pfizer, Inc. (
) and Novartis AG (
). JNJ's current earnings per share, an indicator of a company's
profitability, is $4.5. Zacks Investment Research reports JNJ's
forecasted earnings growth in 2013 as 7.56%, compared to an
industry average of -3%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to JNJ through an Exchange
Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- Select Sector SPDR Fund - Health Care (
- iShares Dow Jones U.S. Health Care Index Fund (
- iShares U.S. Pharmaceutical ETF (
- Vanguard Health Care ETF (
The top-performing ETF of this group is IHE with an increase of
15.09% over the last 100 days. PPH has the highest percent
weighting of JNJ at 9.25%.